Genus, the global animal genetics company, said its full year figures would be in line with expectations after a good performance over the last two months.
The company said pricing had remained firm, with adjusted operating profit improving in line with expectations despite increasing investment in research and growing its management teams.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Going forward, the firm expects strong growth in emerging markets, particularly in China.
The group's businesses in North America also performed well due to cost controls and improved royalty income offsetting softness there.
Europe had performed broadly in line with the prior year, it added.
-
HMRC confirms crypto ETN ISA rulesWith crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch forWine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
